Fig. 5From: A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myelomaGene expression immune profiling for abundance and function of immune cell subsets. The NanoString PanCancer Immune Profiling Panel V1 was used to analyse samples collected at pre-treatment (PRE), C1D21 and C4D1. The relative abundance of A T cells, B B cells or C NK cells, and the pathway signature scores indicating function of D T cells, E B cells and F NK cells are shownBack to article page